Abstract
5 IL-2 therapy increases intratumoral FOXP3 + regulatory immune cells in patients with metastatic renal cell carcinoma
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1111/j.1600-0463.2008.00abs1165_17.x
Copy DOIJournal: Apmis | Publication Date: May 1, 2008 |
5 IL-2 therapy increases intratumoral FOXP3 + regulatory immune cells in patients with metastatic renal cell carcinoma
Join us for a 30 min session where you can share your feedback and ask us any queries you have